Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

oes not include the up-front payments in respect of in-licensed and acquired products made in Q1 2012.
  • Net debt at March 31, 2012 was $214 million (December 31, 2011: $468 million), a reduction of $254 million, principally due to the strong free cash flow generated in Q1 2012.

  • 2012 OUTLOOK


    Having made a strong start to the year, we reiterate our confidence in good earnings growth for 2012, while investing in our business to support sustained future growth.

    For the full year we now expect product sales growth in the mid teens range. Combining this with lower royalties and other revenues, which are expected to be 15% to 25% lower year on year, we are forecasting revenue growth in the low teens range.

    We anticipate the marginal dilution in gross margins seen this quarter will continue, reflecting the full year impact of our acquisition of ABH.

    We will continue to advance our promising pipeline of early and late stage programs, and we will be investing in our recent pipeline acquisitions and in the treatment of binge eating disorder, following recent positive data. The rate of increase in operating costs seen in the first quarter will not continue through the full year, but as we invest in our pipeline, continue to expand our international commercial activities and absorb a full year of ABH's operating costs, we now expect combined Non GAAP R&D and SG&A spending to increase by 12% to 14% compared to 2011.

    We expect our tax rate for 2012 to be in the range of 20% to 22%.

    FIRST QUARTER 2012 AND RECENT PRODUCT AND PIPELINE DEVELOPMENTS


    Products


    VPRIV manufacturing update

    • On February 22, 2012 Shire announced that the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use had approved the production of VPRIV in its new biologics manufacturing facility in Lexington, Massachusetts and this decision
      '/>"/>

    SOURCE Shire plc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

    Related medicine technology :

    1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
    2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
    3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
    4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
    5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
    6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
    7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
    8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
    9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
    10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
    11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/26/2015)... Calif. , May 26, 2015  Accuray Incorporated ... team is scheduled to present at the Jefferies 2015 ... on Wednesday, June 3, 2015 at 2:30pm ET.   ... be available on the Investor Relations page of the ... of the presentation will begin approximately one hour after ...
    (Date:5/26/2015)... Pa. , May 26, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... that Bob Radie , president and chief ... conferences in June. He will provide an update ... (ketorolac tromethamine) Nasal Spray, approved product ...
    (Date:5/22/2015)... - The Taskforce representing Canada,s living ... work that the Minister and Health Canada have put into ... the needs of the thalidomide survivors, and more than 70% ... free, with annual adjustments for inflation. Certain of ... $100,000 based on the severity of their disability, tax free, ...
    Breaking Medicine Technology:Egalet to Present at Upcoming Conferences in June 2Egalet to Present at Upcoming Conferences in June 3
    (Date:5/26/2015)... (PRWEB) May 26, 2015 Based on ... AnyTranscription has undertaken a comprehensive upgrade of its purchasing ... user experience. To thank users for their feedback and ... five minute trial transcription service promotion. , ... May 26 to June 9 this year. During this ...
    (Date:5/26/2015)... Adenna, Inc ., worldwide supplier of ... announce the launch of Enov8 (pronounced “innovate”), ... polyethylene (PE) and approved by the U.S. FDA for ... , The Enov8 glove might look like the PE ... but our proprietary formula and production technology brings to ...
    (Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
    (Date:5/26/2015)... Many sexy cocktail dresses inspired by celebrities ... recently. Now, TheCelebrityDresses.com is offering great discounts on ... off. The company aims to help ladies from ... dollars on valuable, trendy formal outfits. , TheCelebrityDresses.com ... special occasion dresses. Their dresses are popular among ...
    (Date:5/26/2015)... (PRWEB) May 26, 2015 U.S. Food ... in the United States are extensive and can be ... firm that helps medical device companies comply with FDA ... medical device companies navigate FDA requirements. , 1. ... the United States can be a lengthy process depending ...
    Breaking Medicine News(10 mins):Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4
    ... ... in inflammatory bowel diseases (IBD) is changing and improving the ... diseases impacting 1.4 million Americans—are diagnosed and treated. On Tuesday, ... patients, families, and caregivers can tune into a Crohn’s & ...
    ... ... for our consumer safety, Herr Foods Inc of Nottingham, PA is voluntarily recalling ‘Herr’s ... ... As a precautionary measure and concern for our consumer safety, Herr Foods ...
    ... ... value of Intellimed,s Reporting Tool. , ... Phoenix, Ariz. (PRWEB) March 9, 2010 -- Intellimed International Corporation, a ... medical reporting software system Intellimed Intelligent Client (IM-IC)., , ,Always with an ear to ...
    ... ... model and covergirl of the Sports Illustrated Swimsuit edition, shares her secrets on how ... one of America,s longest running TV news magazine and has aired in over 125 ... network. NewsWatch aired its first episode in 1989. , ...
    ... ... ... ... ...
    ... jobs isn,t an option, modifying behavior may help, expert says ... ends meet these days, many Americans are sacrificing sleep to ... though, that lack of sleep can lead to memory problems, ... "In the last couple of years, I,ve seen more overworked ...
    Cached Medicine News:Health News:National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference 2Health News:National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference 3Health News:National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference 4Health News:Herr Foods Inc. Recalls ‘Herr's Cracked Pepper and Sea Salt Flavored' Kettle Style Potato Chips Because of Possible Health Risk 2Health News:Intellimed's Popular Data Reporting Software IM-IC (Intelligent Client) Receives Latest Update 2Health News:Brooklyn Decker Talks with NewsWatch About Tips on how to stay fit and Healthy 2Health News:Brooklyn Decker Talks with NewsWatch About Tips on how to stay fit and Healthy 3Health News:North American Spine Joins Governor Arnold Schwarzenegger at 2010 ICA Symposium 2Health News:North American Spine Joins Governor Arnold Schwarzenegger at 2010 ICA Symposium 3Health News:North American Spine Joins Governor Arnold Schwarzenegger at 2010 ICA Symposium 4Health News:Shift Work Can Put a Crimp on Sleep 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: